Relationship Between Dose and Plasma Level of Digoxin and Patient Characteristics
Overview
Authors
Affiliations
The correlation between the daily dose of digoxin, its plasma level and clinical characteristics of 213 patients receiving beta-acetyldigoxin treatment has been evaluated. After logarithmic transformation of lognormally distributed variables multiple linear regression analysis was performed. Eight predictor variables were chosen: sex, age, height, weight, glycoside dose, creatinine and potassium level in serum and dose of spironolactone. The resulting correlation coefficient was 0.46, i.e. only 100 x r2 = 21.4% of the variance of the steady state digoxin plasma level could be interpreted with the aid of these variables. For only 4 of the 8 variables (age, glycoside dose, serum level of creatinine, and spironolactone dose) were partial coefficients of regression and of correlation significantly different from zero. Almost 80% of the variance could not be accounted for. This finding is in accordance with conclusions in the literature.
Clinical implications of serum digoxin concentrations.
Ochs H, Greenblatt D, Harmatz J, BODEM G, DENGLER H Klin Wochenschr. 1981; 59(10):501-7.
PMID: 7241950 DOI: 10.1007/BF01696212.
A standard approach to compiling clinical pharmacokinetic data.
Sheiner L, Benet L, Pagliaro L J Pharmacokinet Biopharm. 1981; 9(1):59-127.
PMID: 7014827 DOI: 10.1007/BF01059343.
Pharmacokinetics of digoxin in pregnancy.
Luxford A, Kellaway G Eur J Clin Pharmacol. 1983; 25(1):117-21.
PMID: 6617713 DOI: 10.1007/BF00544027.